Pfizer (PFE) and Amgen (AMGN) are among 22 strategic firms looking to expand in Hong Kong under the sixth batch of the government's flagship investment-attraction program, the South China Morning Post reported Monday, citing an unnamed source.

The two companies are expected to sign deals with the Office for Attracting Strategic Enterprises, the paper said.

Pfizer and Amgen did not immediately respond to MT Newswires' requests for comment.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)